AMERICAN ST

Brand Owner (click to sort) Address Description
AMERICAN FIRST RUDNICK, GARY P. 27 HILL RD. GREENWICH CT 06830 AMERICAN 1ST;PROMOTING THE SALE OF GOODS MADE IN THE UNITED STATES;
AMERICAN FIRST American First Corporation P. O. Box 25225 1472 East First National Center Oklahoma City OK 73102 AMERICAN 1ST;LIFE INSURANCE UNDERWRITING SERVICES; SURETY BOND SERVICES; CONSULTING SERVICES IN THE FIELD OF REAL ESTATE INVESTMENT; AND FINANCIAL CONSULTING SERVICES IN CONNECTION WITH REAL ESTATE DEVELOPMENT;
AMERIFIRST AmeriFirst Inc. 814 A1A North Suite 300 Ponte Vedra Beach FL 32082 AMERICAN 1ST; AMERICA 1ST;Insurance services, namely, life insurance underwriting, and insurance brokerage services in the field of securitized travel accident insurance policies;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention provides isolated polynucleotide molecules, including plasmids; viral vectors; and transfected host cells that comprise a DNA sequence encoding an infectious RNA sequence encoding a North American PRRS virus; and also North American PRRS viruses encoded thereby. The invention further provides isolated infectious RNA molecules encoding a North American PRRS virus. The invention also provides isolated polynucleotide molecules, infectious RNA molecules, viral vectors, and transfected host cells encoding genetically-modified North American PRRS viruses; and genetically-modified North American PRRS viruses encoded thereby. The invention also provides vaccines comprising such plasmids, RNA molecules, viral vectors, and North American PRRS viruses, and methods of using these vaccines in swine and in other animals. Also provided are isolated polynucleotide molecules, viral vectors, and transfected host cells that comprise a nucleotide sequence encoding a peptide of a North American PRRS virus. These viral vectors and transfected host cell lines are useful in providing peptides to compensate for mutated peptide coding sequences of DNA sequences encoding genetically-modified North American PRRS viruses so that functional virions can be generated.